Market Tracker

05/02 6:28am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.95
Delayed Data
As of Apr 29
 +0.02 / +0.51%
Today’s Change
3.72
Today|||52-Week Range
8.79
-43.00%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close3.93
Today’s open3.93
Day’s range3.76 - 3.97
Volume20,343
Average volume (3 months)40,190
Market cap$51.8M
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+59.04%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IPCIIntellipharmaceutics...-0.02-0.99%
AVEOAveo Pharmaceuticals...-0.03-3.63%
STDYSteadymed Ltd-0.22-5.22%
PULMPulmatrix Inc+0.08+2.47%
Data as of 04/29/2016

Financials

Next reporting dateMay 11, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts